Cost-effectiveness Analysis Comparing Osia System to Percutaneous Bone Conduction Devices in Sweden
Osia is cost-effective compared with percutaneous devices over a lifetime horizon, when applying low to moderate cost per QALY willingness-to-pay thresholds indicated by the Swedish Agency for Health Technology Assessment and Assessment of Social Services. This analysis provides information on the economic impact of different hearing solutions to support decisions on which BCD best meets the needs of patients and health care budgets.
Authors
- Mimmi Werner (ORCID: https://orcid.org/0000-0002-9031-565X)
- C. Steeds
- Louise Wells (ORCID: https://orcid.org/0009-0005-3785-3087)
- Federico Ghinelli
- Jeremy Wales (ORCID: https://orcid.org/0000-0002-8871-415X)
- Hlíf Sigurgeirsdóttir Liljenberg
- Daniela D’Ostilio
Institutions
- Cochlear (Australia) (AU)
- Karolinska University Hospital (SE)
- Valid International (United Kingdom) (GB)
- Umeå University (SE)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1097/mao.0000000000004761
- Primary Topic
- Ear Surgery and Otitis Media
- Type
- article
- Field-Weighted Citation Impact
- 0.00